Ginkgo Bioworks Holdings (DNA) Treasury Shares (2019 - 2026)

Ginkgo Bioworks Holdings has reported Treasury Shares for 8 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 66.51% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 66.51% YoY), and the FY2025 full-year result was $4.4 million, up 697.76% from the prior year.
• Treasury Shares for Q1 2026 stood at $1.4 million, down from $4.4 million in the prior quarter.
• The five-year high for Treasury Shares was $238.7 million in Q1 2024, with the low at $552457.0 in Q4 2024.
• Historically, Treasury Shares has averaged $65.7 million across 5 years, with a median of $22.4 million in 2024.
• The largest YoY upside for Treasury Shares was 697.76% in 2025 against a maximum downside of 98.28% in 2025.
• Ginkgo Bioworks Holdings' Treasury Shares stood at $134.4 million in 2022, then sank by 97.17% to $3.8 million in 2023, then plunged by 85.48% to $552457.0 in 2024, then jumped by 697.76% to $4.4 million in 2025, then slumped by 68.72% to $1.4 million in 2026.
• The last three Treasury Shares figures came in at $1.4 million (Q1 2026), $4.4 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.